Student Member Price: $10.00

Lipid injectable emulsions (ILEs) are an integral part of balanced parenteral nutrition. While single lipid source, e.g. soybean oil, has previously been the standard of care, mixtures of different lipid emulsions have now become widely available. New lipid products now contain a combination of soybean oil, medium‐chain triglycerides, olive oil, and fish oil. The immunomodulatory and anti-inflammatory benefits of mixed lipid products are supported by growing literature. Additionally, use of these products may improve outcomes in select patient populations. The purpose of this presentation is to review alternative ILEs and discuss their roles in therapy across the continuum of care.

CPE Level: Level 2 (intermediate knowledge/experience)
CPEU: 1.0

Performance Indicators

• 10.4.2 Demonstrates an understanding of pharmacokinetics, absorption, clearance, metabolism, latency periods, accumulation, half-life and routes of drug administration.
• 4.2.6 Integrates relevant information with previous learning, experience, professional knowledge and current practice models.
• 10.3.2 Determines factors impacting client/patient progress in meeting goals and adjusts nutrition care plans accordingly

Learning Objectives

• Describe the role of lipid injectable emulsions (ILEs) and discuss the differences between various formulations.
• Evaluate the literature supporting use of alternative ILEs and their roles in therapy in various patient care settings, including acute, critical care and home care settings.
• Develop appropriate ILE treatment and monitoring plans taking into consideration patient specific variables.

Speakers

• Heather Stanner
• Jackie Johnston